Literature DB >> 8335945

Targeted disruption of CD43 gene enhances T lymphocyte adhesion.

N Manjunath1, R S Johnson, D E Staunton, R Pasqualini, B Ardman.   

Abstract

CD43 is a major leukocyte surface glycoprotein thought to have important functions for T lymphocyte adhesion and activation. We investigated the function of CD43 by using gene targeting to eliminate CD43 expression in the human T lymphocyte line CEM and then testing their adhesive phenotype. Loss of CD43 expression by the CEM cells enhanced their homotypic adhesion and binding to two distinct ligands, fibronectin and HIV-1 gp120. The enhanced homotypic adhesion was blocked specifically by an anti-beta 1 integrin mAb, and the enhanced binding to fibronectin and gp120 was blocked specifically by anti-beta 1 integrin and anti-CD4 mAb, respectively. Partial reconstitution of CD43 expression in the CD43-negative cells resulted in a corresponding reversion to a less adhesive phenotype. These data suggest that CD43 interferes with T lymphocyte adhesion and that CD43 can regulate lymphocyte adhesion by providing a threshold that must be overcome for cell-cell and cell-ligand interactions to occur.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335945

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  CD43, a molecule with multiple functions.

Authors:  Y Rosenstein; A Santana; G Pedraza-Alva
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA.

Authors:  O C Farokhzad; J M Teodoridis; H Park; M A Arnaout; C S Shelley
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

3.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

4.  CD43 is relocated from the basal to the apical plasma membrane of rat uterine epithelial cells by progesterone.

Authors:  L Lecce; Y Kaneko; C R Murphy
Journal:  Histochem Cell Biol       Date:  2010-03-24       Impact factor: 4.304

5.  Signaling through CD43 regulates CD4 T-cell trafficking.

Authors:  Purvi D Mody; Judy L Cannon; Hozefa S Bandukwala; Kelly M Blaine; Alexander B Schilling; Kevin Swier; Anne I Sperling
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

6.  Formation of microvilli and phosphorylation of ERM family proteins by CD43, a potent inhibitor for cell adhesion: cell detachment is a potential cue for ERM phosphorylation and organization of cell morphology.

Authors:  Junko Yamane; Hiroe Ohnishi; Hiroyuki Sasaki; Hisashi Narimatsu; Hajime Ohgushi; Kouichi Tachibana
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

7.  CD43-independent augmentation of mouse T-cell function by glycoprotein cleaving enzymes.

Authors:  Scott B Berger; Amir A Sadighi Akha; Richard A Miller; Gonzalo G Garcia
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

8.  Mucin O-glycan branching enzymes: structure, function, and gene regulation.

Authors:  Pi-Wan Cheng; Prakash Radhakrishnan
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

9.  Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins.

Authors:  Fernando Ruiz-Perez; Rezwanul Wahid; Christina S Faherty; Krishnan Kolappaswamy; Liliana Rodriguez; Araceli Santiago; Ebony Murphy; Alan Cross; Marcelo B Sztein; James P Nataro
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

10.  CD43 Expression Regulated by IL-12 Signaling Is Associated with Survival of CD8 T Cells.

Authors:  Jee-Boong Lee; Jun Chang
Journal:  Immune Netw       Date:  2010-10-31       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.